Labetalol may have an added advantage in that some data suggest that tumor cells express beta 1-, beta 2- and beta 3-adrenergic receptors and that these receptors can mediate tumor cell proliferation and facilitate metastasis [38, 39]. This evidence concerns the gene ADRB3 and neoplasm.